Transcriptionally regulated adenoviruses for prostate-specific gene therapy

World Journal of Urology

Volumn 18, Issue 2, 2000, Pages 93-101

  Lu, Yi ^a,b   Steiner, Mitchell S ^a,b  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b Genotherapeutics Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN BINDING PROTEIN; PROBASIN; PROSTATE SPECIFIC ANTIGEN;

ADENOVIRUS; ANIMAL; ARTICLE; CELL CULTURE; EXPERIMENTAL NEOPLASM; GENE EXPRESSION REGULATION; GENE THERAPY; GENETIC TRANSCRIPTION; GENETICS; HUMAN; LACTOSE OPERON; MALE; METHODOLOGY; MOUSE; MOUSE MAMMARY TUMOR ONCOVIRUS; NUDE MOUSE; PROMOTER REGION; PROSTATE TUMOR; TRANSGENE;

ADENOVIRIDAE; ANDROGEN-BINDING PROTEIN; ANIMALS; GENE EXPRESSION REGULATION, VIRAL; GENE THERAPY; HUMANS; LAC OPERON; MALE; MAMMARY NEOPLASMS, EXPERIMENTAL; MAMMARY TUMOR VIRUS, MOUSE; MICE; MICE, NUDE; PROMOTER REGIONS (GENETICS); PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; TRANSCRIPTION, GENETIC; TRANSGENES; TUMOR CELLS, CULTURED;

EID: 0034168747     PISSN: 07244983     EISSN: None     Source Type: Journal    
DOI: 10.1007/s003450050180     Document Type: Article

References (38)

1. Arbuthnot PB, Bralet MP, Le Jossic C, et al (1996) In vitro and in vivo hepatoma cell-specific expression of a gene transferred with an adenoviral vector. Hum Gene Ther 7: 1503-1514
2. Csete ME, Benhamou PY, Drazan KE, et al (1995) Efficient gene transfer to pancreatic islets mediated by adenoviral vectors. Transplant 59: 263-268
3. Dodd JG, Sheppard PC, Matusik RJ (1983) Characterization and cloning of rat dorsal prostate mRNAs. Androgen regulation of two closely related abundant mRNAs. J Biol Chem 258: 10731-10737
4. Van Y, Sheppard PC, Kasper S. et al (1997) Large fragment of the probasin promoter targets high levels of transgene expression to the prostate of transgenic mice. Prostate 32: 129-139
5. Fire A, Harrison S, Dixon D (1990) A modular set of lacZ fusion vectors for studying gene expression in Caenorhabditis elegans. Gene 93: 189-198
6. Gotoh A, Ko SC, Shirakawa T, et al (1998) Development of prostate-specific antigen promoter-based gene therapy for androgen-independent human prostate cancer. J Urol 160: 220-229
7. Graham FL, Prevec L (1991) Manipulation of adenovirus vectors. Methods in molecular biology. In: Murray EJ (ed) Gene transfer and expression protocol, vol 7. Humana, Clifton, N.J., pp 109-128
8. Greenberg NM, DeMayo FJ, Sheppard PC, et al (1994) The rat probasin gene promoter directs hormonally and developmentally regulated expression of a heterologous gene specifically to the prostate in transgenic mice. Mol Endocrinol 8: 230-239
9. Greenberg NM, DeMayo FJ, Finegold MJ, et al (1995) Prostate cancer in a transgenic mouse. Proc Natl Acad Sei USA 92: 3439-3443
10. Guo ZS, Wang L-H, Eisensmith RC, Woo SLC (1996) Evaluation of promoter strength for hepatic gene expression in vivo following adenovirus-mediated gene transfer. Gene Ther 3: 802-810
11. Halter SA, Dempsey P, Matsui Y, et al (1992) Distinctive patterns of hyperplasia in MMTV-TGFa transgenic mice: characterization of mammary gland and skin proliferations. Am J Pathol 140: 1131-1146
12. Jurincic CD, Pixberg HU, Casser A, Klippel K-F (1990) Prostate-specific antigen in prostatic carcinoma. Urol Int 45: 153-159
13. Karr JF, Kantor JA, Hand PH, et al (1995) The presence of prostate-specific antigen-related genes in primates and the expression of recombinant human prostate-specific antigen in a transfected murine cell line. Cancer Res 55: 2455-2462
14. Kingston RE (1993) Introduction of DNA into mammalian cells. In: Ausübe! FM, Brent R, Kingston RE, et al (eds) Current protocols in molecular biology. Wiley, New York, pp 9.1.4-9.1.9
15. Landis SH, Murray T, Bolden S, Wingo PA (1998) Cancer statistics, 1998. CA 48: 6-30
16. Lee F, Mulligan R, Berg P, Ringold G (1981) Glucocorticoids regulate expression of dihydrofolate reductase cDNA in mouse mammary tumor virus chimaeric plasmids. Nature 294: 228-232
17. Lilja H (1985) A kallikrein-like serine protease in prostatic fluid cleaves the predominant seminal vesicle protein. J Clin Invest 76: 1899-1903
18. Lu Y, Zhang Y, Steiner MS (1998) Efficient identification of recombinant adenoviruses by direct plaque-screening. DNA Cell Biol 17: 643-645
19. Lu Y, Carraher J, Zhang Y, Armstrong J, Lerner J, Roger W, Steiner MS (1999) Delivery of adenoviral vectors to the prostate for gene therapy. Cancer Gene Ther 6: 64-72
20. Matsui Y, Halter SA, Holt JT, et al (1990) Development of mammary hyperplasia and neoplasia in MMTV-TGF-alpha transgenic mice. Cell 61: 1147-1155
21. Matuo Y, Nishi Y, Negi T, et al (1982) Isolation and characterization of androgen-dependent non-histone chromosomal protein from dorsolateral prostate of rats. Biochem Biophys Res Commun 109: 334-340
22. Matuo Y, Adams PS, Nishi N. et al (1989) The androgendependent rat prostate protein, probasin, is a heparin-binding protein that co-purifies with heparin-binding growth factor-1. In Vitro Cell Dev Biol 25: 581-584
23. Mulders TMT, Bruning PF. Bonfrer JMG (1990) Prostatespecific antigen (PSA). A tissue-specific and sensitive tumor marker. Eur J Surg Oncol 16: 371
24. Muller WJ, Lee FS, Dickson C, et al (1990) The int-2 gene product acts as an epithelial growth factor in transgenic mice. EMBO J9: 907-913
25. Oesterling JE (1991) Prostate specific antigen: a critical assessment of the most useful tumor marker for adenocarcinoma of the prostate. J Urol 145: 907-923
26. Otten AD, Sanders MM, McKnight GS (1988) The MMTV LTR promoter is induced by progesterone and dihydrotestosterone but not by estrogen. Mol Endocrinol 2: 143-147
27. Pang S, Taneja S, Dardashti K, et al (1995) Prostate tissue specificity of the prostate-specific antigen promoter isolated from a patient with prostate cancer. Hum Gene Ther 6: 14171426
28. Pierce DF, Johnson MD, Matsui Y, et al (1993) Inhibition of mammary duct development but not alveolar outgrowth during pregnancy in transgenic mice expressing active TGF/?1. Genes Dev 7: 2308-2317
29. Pierce PF Jr, Gorska AE, Chytil A, et al (1995) Mammary tumor suppression by transforming growth factor \transgene expression. Proc Natl Acad Sei USA 92: 4254-4258
30. Rennie PS, Bruchovsky N, Leco KJ, et al (1993) Characterization of two cis-acting DNA elements involved in the androgen regulation of the probasin gene. Mol Endocrinol 7: 23-36
31. Sambrook J (1989) Analysis of genomic DNA by southern hybridization. In: Sambrook J, Fritsch E, Maniatis T (eds) Molecular cloning. Cold Spring Harbor Laboratory, Cold Spring Harbor, New York, pp 9.34-9.45
32. Stamey TA, Yang N, Hay AR, et al (1987) Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate. N Engl J Med 317: 909-916
33. Steiner MS, Anthony C, Paul M, et al (1996) Transforming growth factor /?! overexpression inhibits seminal vesicle development in transgenic mice (abstract 159). J Urol 155: 350
34. Steiner MS, Anthony CT, Lu Y, Holt J (1998) Antisense c-myc retroviral vector suppresses established human prostate cancer. Hum Gene Ther 9: 747-755
35. Tutrone RF, Ball RA, Ornitz DM, et al (1993) Benign prostatic hyperplasia in a transgenic mouse: a new hormonally sensitive investigatory model. J Urol 149: 633-639
36. Wang MC, Valenzuela LA, Murphy GP, et al (1979) Purification of a human prostate-specific antigen. Invest Urol 17: 159-163
37. Watt KW. Lee PJ, M'Timkulu T, et al (1986) Human prostatespecific antigen: structural and functional similarity with serine proteases. Proc Natl Acad Sei USA 83: 3166-3170
38. Zhang W-W, Fang X, Branch CD, et al (1993) Generation and identification of recombinant adenovirus by liposomemediated transfection and PCR analysis. Biotechniques 15: 868-872